🇺🇸 FDA
Patent

US 9623124

Multimodal diagnostic technology for early stage cancer lesions

granted A61KA61K49/0032A61K49/0056

Quick answer

US patent 9623124 (Multimodal diagnostic technology for early stage cancer lesions) held by Northwestern University expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K49/0032, A61K49/0056, A61K49/0058, A61K49/0065